BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1716796)

  • 1. The effect of octreotide acetate on meal-stimulated exocrine secretion in canine pancreatic autografts.
    Garvin PJ; Burton FR; Reese JC; Lingle D; Pandya PK; Niehoff ML
    Transplantation; 1991 Sep; 52(3):453-7. PubMed ID: 1716796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of somatostatin and octreotide acetate on OP-CCK-stimulated exocrine secretion in the denervated canine pancreas.
    Garvin PJ; Burton FR; Reese JC; Dysarz FA; Lingle D; Niehoff ML; Pandya PK; Presti ME
    Pancreas; 1996 Oct; 13(3):304-10. PubMed ID: 8884853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dimethyl PGE2 on canine pancreatic autograft exocrine secretion.
    Garvin PJ; Niehoff M; Burton F
    J Surg Res; 1989 May; 46(5):502-6. PubMed ID: 2469862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of terbutaline on exocrine function in the denervated canine pancreas.
    Garvin PJ; Niehoff M; Burton F
    Transplantation; 1988 Nov; 46(5):739-43. PubMed ID: 2461609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of octreotide on pancreatic endocrine function in partial pancreatectomy.
    Presti M; Niehoff M; Rioux J; Burton F; Garvin P
    J Surg Res; 1996 Mar; 61(2):449-53. PubMed ID: 8656623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A laboratory model for evaluation of posttransplant pancreatic exocrine secretion.
    Garvin PJ; Niehoff M; Burton FR
    J Invest Surg; 1993; 6(1):53-63. PubMed ID: 7680898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral pancreatic enzyme feedback inhibition of the exocrine secretion of the human transplanted pancreas.
    Burton FR; Burton MS; Garvin PJ; Joshi SN
    Transplantation; 1992 Dec; 54(6):988-92. PubMed ID: 1281568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995).
    Kemmer TP; Malfertheiner P; Büchler M; Friess H; Meschenmoser L; Ditschuneit H
    Aliment Pharmacol Ther; 1992 Feb; 6(1):41-50. PubMed ID: 1371938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man.
    Emoto T; Miyata M; Izukura M; Yumiba T; Mizutani S; Sakamoto T; Matsuda H
    Regul Pept; 1997 Jan; 68(1):1-8. PubMed ID: 9094748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of octreotide on stimulated insulin release from pancreatic tissue slices.
    Presti ME; Burton FR; Niehoff ML; Rioux J; Garvin PJ
    Pancreas; 1998 Mar; 16(2):141-7. PubMed ID: 9510136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
    Kayasseh L; Gyr K; Stalder GA; Rittmann WW; Girard J
    Horm Res; 1978; 9(3):176-84. PubMed ID: 640582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of octreotide (SMS 201-995) on meal-stimulated pancreatic secretion in three patients with external pancreatic fistula.
    Gullo L; Biliotti G; Pezzilli R; Di Stefano M; Ancona D
    Am J Gastroenterol; 1991 Jul; 86(7):892-4. PubMed ID: 2058634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of octreotide acetate on pancreatic exocrine and endocrine functions after pancreatoduodenal resection.
    Petrin P; Antoniutti M; Zaramella D; Da Lio C; Basso D; Plebani M; Panozzo MP; Costantino V; Pedrazzoli S
    Eur Surg Res; 1995; 27(6):371-8. PubMed ID: 8542922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of octreotide on exocrine pancreatic secretion in conscious dogs.
    Suzuki T; Naruse S; Yanaihara N
    Pancreas; 1993 Mar; 8(2):226-32. PubMed ID: 8096338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective use of Sandostatin in vascularized pancreas transplantation.
    Stratta RJ; Taylor RJ; Lowell JA; Bynon JS; Cattral M; Langnas AN; Shaw BW
    Am J Surg; 1993 Dec; 166(6):598-604; discussion 604-5. PubMed ID: 7506009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
    Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
    Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of somatostatin on canine exocrine pancreas secretion stimulated by pancreozymin, secretin or test meal].
    Kayasseh L; Stalder GA; Gyr K; Rittmann WW; Girard J
    Schweiz Med Wochenschr; 1977 Apr; 107(15):541-2. PubMed ID: 857313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.